Literature DB >> 25083420

Metastatic sentinel node and axillary lymphadenectomy revisited.

Laia Bernet1, Rafael Cano1.   

Abstract

Year:  2012        PMID： 25083420      PMCID： PMC4115711          DOI： 10.3978/j.issn.2227-684X.2012.04.05

Source DB:  PubMed          Journal:  Gland Surg        ISSN： 2227-684X


× No keyword cloud information.
  8 in total

1.  Incorporation of sentinel lymph node metastasis size into a nomogram predicting nonsentinel lymph node involvement in breast cancer patients with a positive sentinel lymph node.

Authors:  Elizabeth A Mittendorf; Kelly K Hunt; Judy C Boughey; Roland Bassett; Amy C Degnim; Robyn Harrell; Min Yi; Funda Meric-Bernstam; Merrick I Ross; Gildy V Babiera; Henry M Kuerer; Rosa F Hwang
Journal:  Ann Surg       Date:  2012-01       Impact factor: 12.969

Review 2.  Management strategy of early-stage breast cancer patients with a positive sentinel lymph node: With or without axillary lymph node dissection.

Authors:  Jia-Jian Chen; Jiong Wu
Journal:  Crit Rev Oncol Hematol       Date:  2010-07-21       Impact factor: 6.312

Review 3.  Impact of axillary lymph node dissection on breast cancer outcome in clinically node negative patients: a systematic review and meta-analysis.

Authors:  Mona Sanghani; Ethan M Balk; Blake Cady
Journal:  Cancer       Date:  2009-04-15       Impact factor: 6.860

4.  Which prediction models best identify additional axillary disease after a positive sentinel node biopsy for breast cancer?

Authors:  Tanya S Berrang; Mary Lesperance; Pauline T Truong; Caroline Walter; Allen H Hayashi; Ivo A Olivotto
Journal:  Breast Cancer Res Treat       Date:  2012-02-25       Impact factor: 4.872

5.  Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial.

Authors:  Armando E Giuliano; Linda McCall; Peter Beitsch; Pat W Whitworth; Peter Blumencranz; A Marilyn Leitch; Sukamal Saha; Kelly K Hunt; Monica Morrow; Karla Ballman
Journal:  Ann Surg       Date:  2010-09       Impact factor: 12.969

6.  Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial.

Authors:  David N Krag; Stewart J Anderson; Thomas B Julian; Ann M Brown; Seth P Harlow; Joseph P Costantino; Takamaru Ashikaga; Donald L Weaver; Eleftherios P Mamounas; Lynne M Jalovec; Thomas G Frazier; R Dirk Noyes; André Robidoux; Hugh Mc Scarth; Norman Wolmark
Journal:  Lancet Oncol       Date:  2010-10       Impact factor: 41.316

7.  Comparison of molecular analysis and histopathology for axillary lymph node staging in primary breast cancer: results of the B-CLOSER-I study.

Authors:  Laia Bernet Vegué; Federico Rojo; David Hardisson; Alicia Córdoba Iturriagagoitia; Maria José Panadés; Ana Velasco; Eugeni López Bonet; Rafael Cano Muñoz; Luis Polo
Journal:  Diagn Mol Pathol       Date:  2012-06

8.  Accurate staging of axillary lymph nodes from breast cancer patients using a novel molecular method.

Authors:  T Osako; T Iwase; K Kimura; K Yamashita; R Horii; F Akiyama
Journal:  Br J Cancer       Date:  2011-08-30       Impact factor: 7.640
  8 in total
  2 in total

1.  A clinical study on regional lymphatic chemotherapy using an activated carbon nanoparticle-epirubicin in patients with breast cancer.

Authors:  Qian Yang; Xiao-dong Wang; Jie Chen; Chun-xiang Tian; Hong-jiang Li; Yu-Juan Chen; Qing Lv
Journal:  Tumour Biol       Date:  2012-09-05

2.  A support vector machine model for predicting non-sentinel lymph node status in patients with sentinel lymph node positive breast cancer.

Authors:  Xiaowen Ding; Shangnao Xie; Jie Chen; Wenju Mo; Hongjian Yang
Journal:  Tumour Biol       Date:  2013-02-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.